Cathy N Lam

Array ( [id] => 15782297 [patent_doc_number] => 10624850 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-04-21 [patent_title] => Emulsion formulations of an NK-1 receptor antagonist and uses thereof [patent_app_type] => utility [patent_app_number] => 15/965638 [patent_app_country] => US [patent_app_date] => 2018-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 16916 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15965638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16244791 [patent_doc_number] => 10744115 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-08-18 [patent_title] => Compositions and methods for treating traumatic brain injury [patent_app_type] => utility [patent_app_number] => 15/962575 [patent_app_country] => US [patent_app_date] => 2018-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 17 [patent_no_of_words] => 15947 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15962575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13492773 [patent_doc_number] => 20180297929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-18 [patent_title] => GEMCABENE, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR [patent_app_type] => utility [patent_app_number] => 15/956172 [patent_app_country] => US [patent_app_date] => 2018-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 82413 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15956172 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13519337 [patent_doc_number] => 20180311211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-01 [patent_title] => ORAL FORMULATIONS OF PYRROLIDINE DERIVATIVES [patent_app_type] => utility [patent_app_number] => 15/952934 [patent_app_country] => US [patent_app_date] => 2018-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14822 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15952934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16320151 [patent_doc_number] => 10780098 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-09-22 [patent_title] => Non-irritating testosterone emulsions [patent_app_type] => utility [patent_app_number] => 15/948771 [patent_app_country] => US [patent_app_date] => 2018-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5111 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15948771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13090175 [patent_doc_number] => 10064411 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2018-09-04 [patent_title] => Ectoparasiticidal formulations [patent_app_type] => utility [patent_app_number] => 15/947940 [patent_app_country] => US [patent_app_date] => 2018-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2927 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15947940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16336466 [patent_doc_number] => 10787410 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-09-29 [patent_title] => Treating and preventing diseases by modulating cell mechanics [patent_app_type] => utility [patent_app_number] => 15/946849 [patent_app_country] => US [patent_app_date] => 2018-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 80 [patent_no_of_words] => 31803 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15946849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13563733 [patent_doc_number] => 20180333414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-22 [patent_title] => OPHTHALMIC COMPOSITIONS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 15/946709 [patent_app_country] => US [patent_app_date] => 2018-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14759 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15946709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13167901 [patent_doc_number] => 10100054 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2018-10-16 [patent_title] => Pyrido[2,3-d]pyrimidines as anticancer agents [patent_app_type] => utility [patent_app_number] => 15/944734 [patent_app_country] => US [patent_app_date] => 2018-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 2746 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15944734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14116805 [patent_doc_number] => 10245243 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2019-04-02 [patent_title] => Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the S-enantiomer and methods of use [patent_app_type] => utility [patent_app_number] => 15/936849 [patent_app_country] => US [patent_app_date] => 2018-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6044 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15936849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14116803 [patent_doc_number] => 10245242 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2019-04-02 [patent_title] => Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use [patent_app_type] => utility [patent_app_number] => 15/936820 [patent_app_country] => US [patent_app_date] => 2018-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5992 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15936820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14881483 [patent_doc_number] => 10420760 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2019-09-24 [patent_title] => Pharmaceutical compositions and methods of using the same [patent_app_type] => utility [patent_app_number] => 15/935776 [patent_app_country] => US [patent_app_date] => 2018-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 22 [patent_no_of_words] => 30046 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15935776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13574821 [patent_doc_number] => 20180338959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-29 [patent_title] => TREATMENT OF DEPRESSIVE DISORDERS [patent_app_type] => utility [patent_app_number] => 15/933673 [patent_app_country] => US [patent_app_date] => 2018-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12134 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15933673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13533805 [patent_doc_number] => 20180318445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-08 [patent_title] => AMPHIPHILIC CYCLODEXTRIN-BASED GLYCODENDRIMERS [patent_app_type] => utility [patent_app_number] => 15/934698 [patent_app_country] => US [patent_app_date] => 2018-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5886 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15934698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16969265 [patent_doc_number] => 11065211 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-07-20 [patent_title] => Isoxylitones mediated neurogenesis [patent_app_type] => utility [patent_app_number] => 15/934539 [patent_app_country] => US [patent_app_date] => 2018-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 5904 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15934539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14791453 [patent_doc_number] => 10398712 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-09-03 [patent_title] => Compositions and methods for treating multiple sclerosis [patent_app_type] => utility [patent_app_number] => 15/922729 [patent_app_country] => US [patent_app_date] => 2018-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 13066 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15922729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13297351 [patent_doc_number] => 20180200212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-19 [patent_title] => SYSTEMS AND METHODS FOR TREATING VITILIGO [patent_app_type] => utility [patent_app_number] => 15/921752 [patent_app_country] => US [patent_app_date] => 2018-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13038 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15921752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13297439 [patent_doc_number] => 20180200256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-19 [patent_title] => NOVEL METHODS [patent_app_type] => utility [patent_app_number] => 15/918955 [patent_app_country] => US [patent_app_date] => 2018-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18048 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15918955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13410047 [patent_doc_number] => 20180256566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-13 [patent_title] => DUAL MAGL AND FAAH INHIBITORS [patent_app_type] => utility [patent_app_number] => 15/919113 [patent_app_country] => US [patent_app_date] => 2018-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47266 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15919113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16028099 [patent_doc_number] => 10676456 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-06-09 [patent_title] => Polycyclic amines as opioid receptor modulators [patent_app_type] => utility [patent_app_number] => 15/917866 [patent_app_country] => US [patent_app_date] => 2018-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 54711 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 308 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15917866 [rel_patent_id] =>[rel_patent_doc_number] =>)